Company intelligence / Profile preview
Moma Pharma
Caserta, Campania, Italymomapharma.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Moma Pharma (MOMAPHARMA S.r.l.) is an Italian pharmaceutical and nutraceutical company based in Caserta, Italy. The company specializes in the design, research, and distribution of dietary supplements, medical devices, and cosmeceuticals, spanning therapeutic areas from oncology supportive care to vascular health. Its product portfolio includes well-known regional brands such as Temex, Spinner, Ubidren, and Combifer. Following over 15 to 20 years of operation, the company underwent a corporate demerger (scissione), leading to the creation of successor entities Momacare Pharma S.r.l. and Momaprime Pharma S.r.l., and the original entity is currently in liquidation.
- Therapeutic areas
- ImmunologyCardiovascularOncologyGastroenterology
- Modalities
- Small moleculeBotanical extractPlant extractProbiotics
- Industry
- Pharma
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Moma Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Moma Pharma.